Clover Health Investments (CLOV) Cash from Investing Activities (2020 - 2026)

Clover Health Investments (CLOV) has 7 years of Cash from Investing Activities data on file, last reported at -$5.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 156.75% year-over-year to -$5.1 million; the trailing twelve-month figure through Mar 2026 stood at -$9.9 million (down 3300.65% YoY), and the FY2025 full-year result was $4.1 million, up 621.42% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$5.1 million, up from -$35.0 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $89.4 million in Q2 2022 and bottomed at -$43.4 million in Q3 2022.
• The 5-year median for Cash from Investing Activities is $8.9 million (2025), against an average of $13.8 million.
• Peak annual rise in Cash from Investing Activities reached 617.92% in 2025, while the deepest fall reached 2331.9% in 2025.
• A 5-year view of Cash from Investing Activities shows it stood at $12.7 million in 2022, then jumped by 561.05% to $83.7 million in 2023, then slumped by 101.72% to -$1.4 million in 2024, then plunged by 2331.9% to -$35.0 million in 2025, then surged by 85.52% to -$5.1 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.1 million (Q1 2026), -$35.0 million (Q4 2025), and -$5.4 million (Q3 2025), per Business Quant data.

Peer Comparison